Human physiology is the science of the mechanical, physical, and biochemical functions of humans in good health, their organs, and the cells of which they are composed. The principal level of focus of physiology is at the level of organs and systems. Most aspects of human physiology are closely homologous to corresponding aspects of animal physiology, and animal experimentation has provided much of the foundation of physiological knowledge. Anatomy and physiology are closely related fields of study: anatomy, the study of form, and physiology, the study of function, are intrinsically tied and are studied in tandem as part of a medical curriculum.
iWorx, a developer of advanced physiology research and teaching tools, has launched a family of cardiovascular research products used to assess cardiac performance and hemodynamics, both in vivo and in vitro.
The Journal of Biological Chemistry's editors are unveiling this week a number of changes to the journal's publishing policies. They say the changes are in response to the increasingly interdisciplinary nature of biological research and will help the journal better meet the evolving needs of the scientific community.
JSerra Catholic High School and Mission Hospital announced a Pre-Med Professional Magnet program designed for students interested in careers in medicine and healthcare.
Gently rocking embryos while they grow during in vitro fertilization (IVF) improves pregnancy rates in mice by 22 percent, new University of Michigan research shows. The procedure could one day lead to significantly higher IVF success rates in humans.
Sirnaomics, Inc. (www.sirnaomics.com) announced today that the company has licensed a polypeptide nanoparticle technology invented by Professor A. James Mixson of University of Maryland Medical School.
An enzyme that normally helps break down stored fats goes into overdrive in some cancer cells, making them more malignant, according to new findings by a team at The Scripps Research Institute.
Scientists at the Gladstone Institute of Neurological Disease (GIND) have identified the reason a key protein plays a major role in two neurodegenerative diseases.
"We are very happy to be donating money to the fight against breast cancer, especially in light of our own family history," says M-rit Rausing. "Hans's mother and grandmother both died of the disease, and his father, Ruben, put considerable effort into finding a cure. Of course, it's also important when you think that breast cancer is one of the most common diseases."
Curemark, a drug research and development company that focuses on the treatment of neurological diseases, has retained Rubenstein Public Relations to help raise national, regional, and industry awareness of the organization's research, treatments and founder, Dr. Joan Fallon. Curemark is developing an autism treatment that will be one of the first to address the underlying physiology of autism.
Researchers at the Swedish medical university Karolinska Institutet have discovered a new way of blocking the formation of blood vessels and halting the growth of tumours in mice. A substance that exploits this mechanism could be developed into a new treatment for cancer.
The maximum time an athlete is able to continue climbing to exhaustion may be the only determinant of his/her performance. A new European study, led by researchers from the University of Granada, the objective of which is to help trainers and climbers design training programmes for this type of sport, shows this to be the case.
Neuroscientists have forged an unlikely molecular union as part of their fight against diseases of the brain and nervous system.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has discovered a key mechanism related to the systemic delivery of RNAi therapeutics using lipid nanoparticles (LNPs). The new pre-clinical research was presented at the “Advances in Biopharmaceuticals” Keystone Symposium held January 8-13, 2010 in Midway, Utah, and was performed in collaboration with scientists at the Max Planck Institute of Molecular Cell Biology and Genetics.
Dr. Eric J. Topol, chief academic officer of Scripps Health and chief medical officer of the West Wireless Health Institute (WWHI), will join Qualcomm chairman and CEO Dr. Paul E. Jacobs during Jacobs' keynote at International CES on Friday, January 8, 2010, to highlight a variety of digital medical devices that offer physicians and consumers the ability to remotely monitor fitness, sleep, vital signs and pre-natal activity.
Odysseus has developed systems to construct 3D images of individual patients' livers, with their tumours or other pathologies, from MRI or CT-scans. The reconstructions can be transmitted to external experts in any location, for consultation in real time just before surgery.
Bioengineers have taken a small step toward improving physical recovery in stroke patients by showing that a key feature of how limb motion is encoded in the nervous system plays a crucial role in how new motor skills are learned.
Clinical and Laboratory Standards Institute (CLSI) recently published Sweat Testing: Sample Collection and Quantitative Chloride Analysis; Approved Guideline—Third Edition (C34-A3). This document addresses appropriate methods of collection and analysis, quality control, and the evaluation and reporting of sweat test results for the diagnosis of cystic fibrosis.
Clinicians rely on laboratory tests to monitor the progression or remission of disease, or to identify pathologic alterations in physiology that may precede clinical events. Monitoring quantitative laboratory results represents a crucial component in the assessment of response to therapy.
Researchers at the Stanford University School of Medicine have taken an early step toward identifying a new approach to drug discovery that may eventually yield drugs with fewer side effects.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has received a milestone payment from its partner Roche related to initiation of pre-IND (investigational new drug application) studies for an RNAi therapeutics product candidate.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.